1. O'Sullivan JDB, Nicu C, Picard M, Cheret J, Bedogni B, Tobin DJ. et al. The biology of human hair greying. Biol Rev Camb Philos Soc. 2021;96:107–28. [PubMed] [Google Scholar]
2. Ji J, Ho BS, Qian G, Xie XM, Bigliardi PL, Bigliardi-Qi M. Aging in hair follicle stem cells and niche microenvironment. J Dermatol. 2017;44:1097–104. [PubMed] [Google Scholar]
3. Park AM, Khan S, Rawnsley J. Hair Biology: Growth and Pigmentation. Facial Plast Surg Clin North Am. 2018;26:415–24. [PubMed] [Google Scholar]
4. He L, Michailidou F, Gahlon HL, Zeng W. Hair Dye Ingredients and Potential Health Risks from Exposure to Hair Dyeing. Chem Res Toxicol. 2022;35:901–15. [PMC free article] [PubMed] [Google Scholar]
5. Rosenberg A, Rausser S, Ren J, Mosharov E, Sturm G, Ogden R, Quantitative mapping of human hair greying and reversal in relation to life stress. eLife. 2021. 10. [PMC free article] [PubMed]
6. Fernandez-Flores A, Saeb-Lima M, Cassarino DS. Histopathology of aging of the hair follicle. J Cutan Pathol. 2019;46:508–19. [PubMed] [Google Scholar]
7. Wu X, Hammer JA. Melanosome transfer: it is best to give and receive. Curr Opin Cell Biol. 2014;29:1–7. [PMC free article] [PubMed] [Google Scholar]
8. Sun Q, Lee W, Hu H, Ogawa T, De Leon S, Katehis I, Dedifferentiation maintains melanocyte stem cells in a dynamic niche. Nature. 2023. [PMC free article] [PubMed]
9. Tobin D, Hagen E, Botchkarev V, Paus R. Do hair bulb melanocytes undergo apoptosis during hair follicle regression (catagen)? The Journal of investigative dermatology. 1998;111:941–7. [PubMed] [Google Scholar]
10. Slominski A, Wortsman J, Plonka P, Schallreuter K, Paus R, Tobin D. Hair follicle pigmentation. The Journal of investigative dermatology. 2005;124:13–21. [PMC free article] [PubMed] [Google Scholar]
11. Oh JW, Kloepper J, Langan EA, Kim Y, Yeo J, Kim MJ. et al. A Guide to Studying Human Hair Follicle Cycling In vivo. J Invest Dermatol. 2016;136:34–44. [PMC free article] [PubMed] [Google Scholar]
12. Tobin D. A possible role for Langerhans cells in the removal of melanin from early catagen hair follicles. The British journal of dermatology. 1998;138:795–8. [PubMed] [Google Scholar]
13. Tobin D, Slominski A, Botchkarev V, Paus R. The fate of hair follicle melanocytes during the hair growth cycle. The journal of investigative dermatology Symposium proceedings. 1999;4:323–32. [PubMed] [Google Scholar]
14. Commo S, Bernard B. Melanocyte subpopulation turnover during the human hair cycle: an immunohistochemical study. Pigment cell research. 2000;13:253–9. [PubMed] [Google Scholar]
15. Nishimura E, Jordan S, Oshima H, Yoshida H, Osawa M, Moriyama M. et al. Dominant role of the niche in melanocyte stem-cell fate determination. Nature. 2002;416:854–60. [PubMed] [Google Scholar]
16. Commo S, Gaillard O, Bernard B. Human hair greying is linked to a specific depletion of hair follicle melanocytes affecting both the bulb and the outer root sheath. The British journal of dermatology. 2004;150:435–43. [PubMed] [Google Scholar]
17. Nishimura EK, Granter SR, Fisher DE. Mechanisms of hair graying: incomplete melanocyte stem cell maintenance in the niche. Science. 2005;307:720–4. [PubMed] [Google Scholar]
18. Tanimura S, Tadokoro Y, Inomata K, Binh NT, Nishie W, Yamazaki S. et al. Hair follicle stem cells provide a functional niche for melanocyte stem cells. Cell Stem Cell. 2011;8:177–87. [PubMed] [Google Scholar]
19. Lu Z, Xie Y, Huang H, Jiang K, Zhou B, Wang F, Hair follicle stem cells regulate retinoid metabolism to maintain the self-renewal niche for melanocyte stem cells. Elife. 2020. 9. [PMC free article] [PubMed]
20. Wu S, Yu Y, Liu C, Zhang X, Zhu P, Peng Y. et al. Single-cell transcriptomics reveals lineage trajectory of human scalp hair follicle and informs mechanisms of hair graying. Cell Discov. 2022;8:49. [PMC free article] [PubMed] [Google Scholar]
21. Arck PC, Overall R, Spatz K, Liezman C, Handjiski B, Klapp BF. et al. Towards a "free radical theory of graying": melanocyte apoptosis in the aging human hair follicle is an indicator of oxidative stress induced tissue damage. FASEB J. 2006;20:1567–9. [PubMed] [Google Scholar]
22. Takeo M, Lee W, Rabbani P, Sun Q, Hu H, Lim CH. et al. EdnrB Governs Regenerative Response of Melanocyte Stem Cells by Crosstalk with Wnt Signaling. Cell Rep. 2016;15:1291–302. [PMC free article] [PubMed] [Google Scholar]
23. Rabbani P, Takeo M, Chou W, Myung P, Bosenberg M, Chin L. et al. Coordinated activation of Wnt in epithelial and melanocyte stem cells initiates pigmented hair regeneration. Cell. 2011;145:941–55. [PMC free article] [PubMed] [Google Scholar]
24. Choi BY. Targeting Wnt/beta-Catenin Pathway for Developing Therapies for Hair Loss. Int J Mol Sci. 2020. 21. [PMC free article] [PubMed]
25. Yardman-Frank JM, Fisher DE. Skin pigmentation and its control: From ultraviolet radiation to stem cells. Experimental Dermatology. 2020;30:560–71. [PMC free article] [PubMed] [Google Scholar]
26. Li C, Kuai L, Cui R, Miao X. Melanogenesis and the Targeted Therapy of Melanoma. Biomolecules. 2022. 12. [PMC free article] [PubMed]
27. Manning D, Dart C, Evans RL. Store-operated calcium channels in skin. Front Physiol. 2022;13:1033528. [PMC free article] [PubMed] [Google Scholar]
28. Motiani RK, Tanwar J, Raja DA, Vashisht A, Khanna S, Sharma S, STIM1 activation of adenylyl cyclase 6 connects Ca(2+) and cAMP signaling during melanogenesis. EMBO J. 2018. 37. [PMC free article] [PubMed]
29. Shah P, He YY. Molecular regulation of UV-induced DNA repair. Photochem Photobiol. 2015;91:254–64. [PMC free article] [PubMed] [Google Scholar]
30. Chou WC, Takeo M, Rabbani P, Hu H, Lee W, Chung YR. et al. Direct migration of follicular melanocyte stem cells to the epidermis after wounding or UVB irradiation is dependent on Mc1r signaling. Nat Med. 2013;19:924–9. [PMC free article] [PubMed] [Google Scholar]
31. Ahn JH, Jin SH, Kang HY. LPS induces melanogenesis through p38 MAPK activation in human melanocytes. Arch Dermatol Res. 2008;300:325–9. [PubMed] [Google Scholar]
32. Qian W, Liu W, Zhu D, Cao Y, Tang A, Gong G. et al. Natural skin-whitening compounds for the treatment of melanogenesis (Review) Exp Ther Med. 2020;20:173–85. [PMC free article] [PubMed] [Google Scholar]
33. Hou L, Panthier J, Arnheiter H. Signaling and transcriptional regulation in the neural crest-derived melanocyte lineage: interactions between KIT and MITF. Development (Cambridge, England) 2000;127:5379–89. [PubMed] [Google Scholar]
34. Sato-Jin K, Nishimura EK, Akasaka E, Huber W, Nakano H, Miller A. et al. Epistatic connections between microphthalmia-associated transcription factor and endothelin signaling in Waardenburg syndrome and other pigmentary disorders. FASEB J. 2008;22:1155–68. [PubMed] [Google Scholar]
35. Terazawa S, Imokawa G. Signaling Cascades Activated by UVB in Human Melanocytes Lead to the Increased Expression of Melanocyte Receptors, Endothelin B Receptor and c-KIT. Photochem Photobiol. 2018;94:421–31. [PubMed] [Google Scholar]
36. Nakajima H, Wakabayashi Y, Wakamatsu K, Imokawa G. An extract of Withania somnifera attenuates endothelin-1-stimulated pigmentation in human epidermal equivalents through the interruption of PKC activity within melanocytes. Phytother Res. 2011;25:1398–411. [PubMed] [Google Scholar]
37. Hwang E, Lee TH, Lee W-J, Shim W-S, Yeo E-J, Kim S. et al. A novel syntheticPiperamide derivative NED-180 inhibits hyperpigmentation by activating the PI3K and ERK pathways and by regulating Ca2+influx via TRPM1 channels. Pigment Cell & Melanoma Research. 2016;29:81–91. [PubMed] [Google Scholar]
38. Mosca S, Cardinali G, Flori E, Briganti S, Bottillo I, Mileo AM. et al. The PI3K pathway induced by alphaMSH exerts a negative feedback on melanogenesis and contributes to the release of pigment. Pigment Cell Melanoma Res. 2021;34:72–88. [PubMed] [Google Scholar]
39. Jeon S, Kim NH, Kim JY, Lee AY. Stem cell factor induces ERM proteins phosphorylation through PI3K activation to mediate melanocyte proliferation and migration. Pigment Cell Melanoma Res. 2009;22:77–85. [PubMed] [Google Scholar]
40. Todd JR, Scurr LL, Becker TM, Kefford RF, Rizos H. The MAPK pathway functions as a redundant survival signal that reinforces the PI3K cascade in c-Kit mutant melanoma. Oncogene. 2014;33:236–45. [PubMed] [Google Scholar]
41. Nishimura EK, Suzuki M, Igras V, Du J, Lonning S, Miyachi Y. et al. Key roles for transforming growth factor beta in melanocyte stem cell maintenance. Cell Stem Cell. 2010;6:130–40. [PMC free article] [PubMed] [Google Scholar]
42. Murakami M, Matsuzaki F, Funaba M. Regulation of melanin synthesis by the TGF-beta family in B16 melanoma cells. Mol Biol Rep. 2009;36:1247–50. [PubMed] [Google Scholar]
43. Klar AS, Biedermann T, Michalak K, Michalczyk T, Meuli-Simmen C, Scherberich A. et al. Human Adipose Mesenchymal Cells Inhibit Melanocyte Differentiation and the Pigmentation of Human Skin via Increased Expression of TGF-beta1. J Invest Dermatol. 2017;137:2560–9. [PubMed] [Google Scholar]
44. Joompang A, Anwised P, Klaynongsruang S, Roytrakul S, Taemaitree L, Jangpromma N. Evaluation of TILI-2 as an Anti-Tyrosinase, Anti-Oxidative Agent and Its Role in Preventing Melanogenesis Using a Proteomics Approach. Molecules. 2022. 27. [PMC free article] [PubMed]
45. Martinez-Esparza M, Jimenez-Cervantes C, Beermann F, Aparicio P, Lozano JA, Garcia-Borron JC. Transforming growth factor-beta1 inhibits basal melanogenesis in B16/F10 mouse melanoma cells by increasing the rate of degradation of tyrosinase and tyrosinase-related protein-1. J Biol Chem. 1997;272:3967–72. [PubMed] [Google Scholar]
46. Kubic JD, Young KP, Plummer RS, Ludvik AE, Lang D. Pigmentation PAX-ways: the role of Pax3 in melanogenesis, melanocyte stem cell maintenance, and disease. Pigment Cell Melanoma Res. 2008;21:627–45. [PMC free article] [PubMed] [Google Scholar]
47. Yang G, Li Y, Nishimura EK, Xin H, Zhou A, Guo Y. et al. Inhibition of PAX3 by TGF-beta modulates melanocyte viability. Mol Cell. 2008;32:554–63. [PubMed] [Google Scholar]
48. Kim DS, Park SH, Park KC. Transforming growth factor-beta1 decreases melanin synthesis via delayed extracellular signal-regulated kinase activation. Int J Biochem Cell Biol. 2004;36:1482–91. [PubMed] [Google Scholar]
49. Moon HR, Jung JM, Kim SY, Song Y, Chang SE. TGF-beta3 suppresses melanogenesis in human melanocytes cocultured with UV-irradiated neighboring cells and human skin. J Dermatol Sci. 2020;99:100–8. [PubMed] [Google Scholar]
50. Hibino T, Nishiyama T. Role of TGF-beta2 in the human hair cycle. J Dermatol Sci. 2004;35:9–18. [PubMed] [Google Scholar]
51. Li S, Chen J, Chen F, Wang C, Guo X, Wang C. et al. Liposomal honokiol promotes hair growth via activating Wnt3a/beta-catenin signaling pathway and down regulating TGF-beta1 in C57BL/6N mice. Biomed Pharmacother. 2021;141:111793. [PubMed] [Google Scholar]
52. Pierrat MJ, Marsaud V, Mauviel A, Javelaud D. Expression of microphthalmia-associated transcription factor (MITF), which is critical for melanoma progression, is inhibited by both transcription factor GLI2 and transforming growth factor-beta. J Biol Chem. 2012;287:17996–8004. [PMC free article] [PubMed] [Google Scholar]
53. Pierrat MJ, Marsaud V, Mauviel A, Javelaud D. Transcriptional repression of the tyrosinase-related protein 2 gene by transforming growth factor-beta and the Kruppel-like transcription factor GLI2. J Dermatol Sci. 2019;94:321–9. [PubMed] [Google Scholar]
54. Steingrimsson E, Copeland NG, Jenkins NA. Melanocyte stem cell maintenance and hair graying. Cell. 2005;121:9–12. [PubMed] [Google Scholar]
55. Gelmi MC, Houtzagers LE, Strub T, Krossa I, Jager MJ. MITF in Normal Melanocytes, Cutaneous and Uveal Melanoma: A Delicate Balance. Int J Mol Sci. 2022. 23. [PMC free article] [PubMed]
56. Goding CR, Arnheiter H. MITF-the first 25 years. Genes Dev. 2019;33:983–1007. [PMC free article] [PubMed] [Google Scholar]
57. Du J, Widlund HR, Horstmann MA, Ramaswamy S, Ross K, Huber WE. et al. Critical role of CDK2 for melanoma growth linked to its melanocyte-specific transcriptional regulation by MITF. Cancer Cell. 2004;6:565–76. [PubMed] [Google Scholar]
58. Carreira S, Liu B, Goding CR. The gene encoding the T-box factor Tbx2 is a target for the microphthalmia-associated transcription factor in melanocytes. J Biol Chem. 2000;275:21920–7. [PubMed] [Google Scholar]
59. Jacobs J, Keblusek P, Robanus-Maandag E, Kristel P, Lingbeek M, Nederlof P. et al. Senescence bypass screen identifies TBX2, which represses Cdkn2a (p19(ARF)) and is amplified in a subset of human breast cancers. Nature genetics. 2000;26:291–9. [PubMed] [Google Scholar]
60. Prince S, Carreira S, Vance K, Abrahams A, Goding C. Tbx2 directly represses the expression of the p21(WAF1) cyclin-dependent kinase inhibitor. Cancer research. 2004;64:1669–74. [PubMed] [Google Scholar]
61. Strub T, Giuliano S, Ye T, Bonet C, Keime C, Kobi D. et al. Essential role of microphthalmia transcription factor for DNA replication, mitosis and genomic stability in melanoma. Oncogene. 2011;30:2319–32. [PubMed] [Google Scholar]
62. McGill G, Horstmann M, Widlund H, Du J, Motyckova G, Nishimura E. et al. Bcl2 regulation by the melanocyte master regulator Mitf modulates lineage survival and melanoma cell viability. Cell. 2002;109:707–18. [PubMed] [Google Scholar]
63. Dynek JN, Chan SM, Liu J, Zha J, Fairbrother WJ, Vucic D. Microphthalmia-associated transcription factor is a critical transcriptional regulator of melanoma inhibitor of apoptosis in melanomas. Cancer Res. 2008;68:3124–32. [PubMed] [Google Scholar]
64. Beuret L, Flori E, Denoyelle C, Bille K, Busca R, Picardo M. et al. Up-regulation of MET expression by alpha-melanocyte-stimulating hormone and MITF allows hepatocyte growth factor to protect melanocytes and melanoma cells from apoptosis. J Biol Chem. 2007;282:14140–7. [PubMed] [Google Scholar]
65. Levy C, Khaled M, Robinson KC, Veguilla RA, Chen PH, Yokoyama S. et al. Lineage-specific transcriptional regulation of DICER by MITF in melanocytes. Cell. 2010;141:994–1005. [PMC free article] [PubMed] [Google Scholar]
66. Zhang J, Mou Y, Gong H, Chen H, Xiao H. Microphthalmia-Associated Transcription Factor in Senescence and Age-Related Diseases. Gerontology. 2021;67:708–17. [PubMed] [Google Scholar]
67. Seoane M, Buhs S, Iglesias P, Strauss J, Puller AC, Muller J. et al. Lineage-specific control of TFIIH by MITF determines transcriptional homeostasis and DNA repair. Oncogene. 2019;38:3616–35. [PMC free article] [PubMed] [Google Scholar]
68. Liu F, Fu Y, Meyskens FL Jr. MiTF regulates cellular response to reactive oxygen species through transcriptional regulation of APE-1/Ref-1. J Invest Dermatol. 2009;129:422–31. [PMC free article] [PubMed] [Google Scholar]
69. Buscà R, Berra E, Gaggioli C, Khaled M, Bille K, Marchetti B. et al. Hypoxia-inducible factor 1{alpha} is a new target of microphthalmia-associated transcription factor (MITF) in melanoma cells. The Journal of cell biology. 2005;170:49–59. [PMC free article] [PubMed] [Google Scholar]
70. Vazquez F, Lim JH, Chim H, Bhalla K, Girnun G, Pierce K. et al. PGC1alpha expression defines a subset of human melanoma tumors with increased mitochondrial capacity and resistance to oxidative stress. Cancer Cell. 2013;23:287–301. [PMC free article] [PubMed] [Google Scholar]
71. Tanwar J, Sharma A, Saurav S, Shyamveer, Jatana N, Motiani R. MITF is a novel transcriptional regulator of the calcium sensor STIM1: Significance in physiological melanogenesis. The Journal of biological chemistry. 2022;298:102681. [PMC free article] [PubMed] [Google Scholar]
72. Chen J, Zheng Y, Hu C, Jin X, Chen X, Xiao Y. et al. Hair Graying Regulators Beyond Hair Follicle. Front Physiol. 2022;13:839859. [PMC free article] [PubMed] [Google Scholar]
73. Brownell I, Guevara E, Bai CB, Loomis CA, Joyner AL. Nerve-derived sonic hedgehog defines a niche for hair follicle stem cells capable of becoming epidermal stem cells. Cell Stem Cell. 2011;8:552–65. [PMC free article] [PubMed] [Google Scholar]
74. Stecca B, Mas C, Clement V, Zbinden M, Correa R, Piguet V. et al. Melanomas require HEDGEHOG-GLI signaling regulated by interactions between GLI1 and the RAS-MEK/AKT pathways. Proceedings of the National Academy of Sciences of the United States of America. 2007;104:5895–900. [PMC free article] [PubMed] [Google Scholar]
75. Zhang B, Ma S, Rachmin I, He M, Baral P, Choi S. et al. Hyperactivation of sympathetic nerves drives depletion of melanocyte stem cells. Nature. 2020;577:676–81. [PMC free article] [PubMed] [Google Scholar]
76. Yuan XH, Jin ZH. Paracrine regulation of melanogenesis. Br J Dermatol. 2018;178:632–9. [PubMed] [Google Scholar]
77. Moattari CR, Granstein RD. Neuropeptides and neurohormones in immune, inflammatory and cellular responses to ultraviolet radiation. Acta Physiol (Oxf) 2021;232:e13644. [PubMed] [Google Scholar]
78. Samuelov L, Kinori M, Bertolini M, Paus R. Neural controls of human hair growth: calcitonin gene-related peptide (CGRP) induces catagen. J Dermatol Sci. 2012;67:153–5. [PubMed] [Google Scholar]
79. Pi LQ, Jin XH, Hwang ST, Lee WS. Effects of calcitonin gene-related peptide on the immune privilege of human hair follicles. Neuropeptides. 2013;47:51–7. [PubMed] [Google Scholar]
80. Toyoda M, Luo Y, Makino T, Matsui C, Morohashi M. Calcitonin gene-related peptide upregulates melanogenesis and enhances melanocyte dendricity via induction of keratinocyte-derived melanotrophic factors. J Investig Dermatol Symp Proc. 1999;4:116–25. [PubMed] [Google Scholar]
81. Zhao J, Harada N, Kurihara H, Nakagata N, Okajima K. Dietary isoflavone increases insulin-like growth factor-I production, thereby promoting hair growth in mice. J Nutr Biochem. 2011;22:227–33. [PubMed] [Google Scholar]
82. Zhou J, Feng JY, Wang Q, Shang J. Calcitonin gene-related peptide cooperates with substance P to inhibit melanogenesis and induces apoptosis of B16F10 cells. Cytokine. 2015;74:137–44. [PubMed] [Google Scholar]
83. Liu N, Wang LH, Guo LL, Wang GQ, Zhou XP, Jiang Y. et al. Chronic restraint stress inhibits hair growth via substance P mediated by reactive oxygen species in mice. PLoS One. 2013;8:e61574. [PMC free article] [PubMed] [Google Scholar]
84. Peters EM, Liotiri S, Bodo E, Hagen E, Biro T, Arck PC. et al. Probing the effects of stress mediators on the human hair follicle: substance P holds central position. Am J Pathol. 2007;171:1872–86. [PMC free article] [PubMed] [Google Scholar]
85. Peters EM, Arck PC, Paus R. Hair growth inhibition by psychoemotional stress: a mouse model for neural mechanisms in hair growth control. Exp Dermatol. 2006;15:1–13. [PubMed] [Google Scholar]
86. Paus R, Arck P, Tiede S. (Neuro-)endocrinology of epithelial hair follicle stem cells. Mol Cell Endocrinol. 2008;288:38–51. [PubMed] [Google Scholar]
87. Ping F, Shang J, Zhou J, Song J, Zhang L. Activation of neurokinin-1 receptor by substance P inhibits melanogenesis in B16-F10 melanoma cells. Int J Biochem Cell Biol. 2012;44:2342–8. [PubMed] [Google Scholar]
88. Zhou J, Geng KK, Ping FF, Gao YY, Liu L, Feng BN. Cross-talk between 5-hydroxytryptamine and substance P in the melanogensis and apoptosis of B16F10 melanoma cells. Eur J Pharmacol. 2016;775:106–12. [PubMed] [Google Scholar]
89. Wu H, Zhao Y, Huang Q, Cai M, Pan Q, Fu M. et al. NK1R/5-HT1AR interaction is related to the regulation of melanogenesis. FASEB J. 2018;32:3193–214. [PubMed] [Google Scholar]
90. Chen M, Cai J, Zhang X, Liao Z, Zhong M, Shang J. et al. Keratinocytes take part in the regulation of substance P in melanogenesis through the HPA axis. J Dermatol Sci. 2022;106:141–9. [PubMed] [Google Scholar]
91. Park PJ, Lee TR, Cho EG. Substance P stimulates endothelin 1 secretion via endothelin-converting enzyme 1 and promotes melanogenesis in human melanocytes. J Invest Dermatol. 2015;135:551–9. [PubMed] [Google Scholar]
92. Zhou J, Ling J, Song H, Lv B, Wang L, Shang J. et al. Neurokinin-1 receptor is a novel positive regulator of Wnt/ β-catenin signaling in melanogenesis. Oncotarget. 2016;7:81268–80. [PMC free article] [PubMed] [Google Scholar]
93. Bertolini M, Pretzlaff M, Sulk M, Bahr M, Gherardini J, Uchida Y. et al. Vasoactive intestinal peptide, whose receptor-mediated signalling may be defective in alopecia areata, provides protection from hair follicle immune privilege collapse. Br J Dermatol. 2016;175:531–41. [PubMed] [Google Scholar]
94. Yuan XH, Yao C, Oh JH, Park CH, Tian YD, Han M. et al. Vasoactive intestinal peptide stimulates melanogenesis in B16F10 mouse melanoma cells via CREB/MITF/tyrosinase signaling. Biochem Biophys Res Commun. 2016;477:336–42. [PubMed] [Google Scholar]
95. Guerrero-Juarez CF, Plikus MV. Emerging nonmetabolic functions of skin fat. Nat Rev Endocrinol. 2018;14:163–73. [PMC free article] [PubMed] [Google Scholar]
96. Kruglikov IL, Zhang Z, Scherer PE. The Role of Immature and Mature Adipocytes in Hair Cycling. Trends Endocrinol Metab. 2019;30:93–105. [PMC free article] [PubMed] [Google Scholar]
97. Zwick RK, Guerrero-Juarez CF, Horsley V, Plikus MV. Anatomical, Physiological, and Functional Diversity of Adipose Tissue. Cell Metab. 2018;27:68–83. [PMC free article] [PubMed] [Google Scholar]
98. Nicu C, O'Sullivan JDB, Ramos R, Timperi L, Lai T, Farjo N. et al. Dermal Adipose Tissue Secretes HGF to Promote Human Hair Growth and Pigmentation. J Invest Dermatol. 2021;141:1633–45. e13. [PubMed] [Google Scholar]
99. Chen J, Fan ZX, Zhu DC, Guo YL, Ye K, Dai D. et al. Emerging Role of Dermal White Adipose Tissue in Modulating Hair Follicle Development During Aging. Front Cell Dev Biol. 2021;9:728188. [PMC free article] [PubMed] [Google Scholar]
100. Won CH, Yoo HG, Park KY, Shin SH, Park WS, Park PJ. et al. Hair growth-promoting effects of adiponectin in vitro. J Invest Dermatol. 2012;132:2849–51. [PubMed] [Google Scholar]
101. Park PJ, Cho EG. Kojyl Cinnamate Ester Derivatives Increase Adiponectin Expression and Stimulate Adiponectin-Induced Hair Growth Factors in Human Dermal Papilla Cells. Int J Mol Sci. 2019. 20. [PMC free article] [PubMed]
102. Ohn J, Been KW, Kim JY, Kim EJ, Park T, Yoon HJ. et al. Discovery of a transdermally deliverable pentapeptide for activating AdipoR1 to promote hair growth. EMBO Mol Med. 2021;13:e13790. [PMC free article] [PubMed] [Google Scholar]
103. Nicu C, Jackson J, Shahmalak A, Pople J, Ansell D, Paus R. Adiponectin negatively regulates pigmentation, Wnt/β-catenin and HGF/c-Met signalling within human scalp hair follicles ex vivo. Arch Dermatol Res. 2023;315:603–12. [PubMed] [Google Scholar]
104. Bang S, Won KH, Moon HR, Yoo H, Hong A, Song Y. et al. Novel regulation of melanogenesis by adiponectin via the AMPK/CRTC pathway. Pigment Cell Melanoma Res. 2017;30:553–7. [PubMed] [Google Scholar]
105. Kim Y, Cho JY, Oh SW, Kang M, Lee SE, Jung E. et al. Globular adiponectin acts as a melanogenic signal in human epidermal melanocytes. Br J Dermatol. 2018;179:689–701. [PubMed] [Google Scholar]
106. Xiong M, Zhang Q, Hu W, Zhao C, Lv W, Yi Y. et al. Exosomes From Adipose-Derived Stem Cells: The Emerging Roles and Applications in Tissue Regeneration of Plastic and Cosmetic Surgery. Front Cell Dev Biol. 2020;8:574223. [PMC free article] [PubMed] [Google Scholar]
107. Mazini L, Rochette L, Admou B, Amal S, Malka G. Hopes and Limits of Adipose-Derived Stem Cells (ADSCs) and Mesenchymal Stem Cells (MSCs) in Wound Healing. Int J Mol Sci. 2020. 21. [PMC free article] [PubMed]
108. Tak YJ, Lee SY, Cho AR, Kim YS. A randomized, double-blind, vehicle-controlled clinical study of hair regeneration using adipose-derived stem cell constituent extract in androgenetic alopecia. Stem Cells Transl Med. 2020;9:839–49. [PMC free article] [PubMed] [Google Scholar]
109. Wu J, Yang Q, Wu S, Yuan R, Zhao X, Li Y. et al. Adipose-Derived Stem Cell Exosomes Promoted Hair Regeneration. Tissue Eng Regen Med. 2021;18:685–91. [PMC free article] [PubMed] [Google Scholar]
110. Nilforoushzadeh MA, Aghdami N, Taghiabadi E. Effects of Adipose-Derived Stem Cells and Platelet-Rich Plasma Exosomes on The Inductivity of Hair Dermal Papilla Cells. Cell J. 2021;23:576–83. [PMC free article] [PubMed] [Google Scholar]
111. Liang Y, Tang X, Zhang X, Cao C, Yu M, Wan M. Adipose Mesenchymal Stromal Cell-Derived Exosomes Carrying MiR-122-5p Antagonize the Inhibitory Effect of Dihydrotestosterone on Hair Follicles by Targeting the TGF-beta1/SMAD3 Signaling Pathway. Int J Mol Sci. 2023. 24. [PMC free article] [PubMed]
112. Lu Q, Gao Y, Fan Z, Xiao X, Chen Y, Si Y. et al. Amphiregulin promotes hair regeneration of skin-derived precursors via the PI3K and MAPK pathways. Cell Prolif. 2021;54:e13106. [PMC free article] [PubMed] [Google Scholar]
113. Anderi R, Makdissy N, Azar A, Rizk F, Hamade A. Cellular therapy with human autologous adipose-derived adult cells of stromal vascular fraction for alopecia areata. Stem Cell Res Ther. 2018;9:141. [PMC free article] [PubMed] [Google Scholar]
114. Kim DW, Jeon BJ, Hwang NH, Kim MS, Park SH, Dhong ES. et al. Adipose-derived stem cells inhibit epidermal melanocytes through an interleukin-6-mediated mechanism. Plast Reconstr Surg. 2014;134:470–80. [PubMed] [Google Scholar]
115. Chang H, Park JH, Min KH, Lee RS, Kim EK. Whitening effects of adipose-derived stem cells: a preliminary in vivo study. Aesthetic Plast Surg. 2014;38:230–3. [PubMed] [Google Scholar]
116. Jeon BJ, Kim DW, Kim MS, Park SH, Dhong ES, Yoon ES. et al. Protective effects of adipose-derived stem cells against UVB-induced skin pigmentation. J Plast Surg Hand Surg. 2016;50:336–42. [PubMed] [Google Scholar]
117. Dou S, Yang Y, Zhang J, He Z, Wu Z, Zhao Y. et al. Exploring the Role and Mechanism of Adipose Derived Mesenchymal Stem Cells on Reversal of Pigmentation Model Effects. Aesthetic Plast Surg. 2022;46:1983–96. [PubMed] [Google Scholar]
118. Shen JP, Wu YX, Tang SJ, Peng LH. Experimental study on stromal vascular fraction mediated inhibition of skin pigmentation in guinea pigs. Ann Transl Med. 2022;10:1268. [PMC free article] [PubMed] [Google Scholar]
119. Kim JY, Park CD, Lee JH, Lee CH, Do BR, Lee AY. Co-culture of melanocytes with adipose-derived stem cells as a potential substitute for co-culture with keratinocytes. Acta Derm Venereol. 2012;92:16–23. [PubMed] [Google Scholar]
120. Lim WS, Kim CH, Kim JY, Do BR, Kim EJ, Lee AY. Adipose-derived stem cells improve efficacy of melanocyte transplantation in animal skin. Biomol Ther (Seoul) 2014;22:328–33. [PMC free article] [PubMed] [Google Scholar]
121. Kim H, Yi N, Do BR, Lee AY. Adipose-Derived Stem Cell Coculturing Stimulates Integrin-Mediated Extracellular Matrix Adhesion of Melanocytes by Upregulating Growth Factors. Biomol Ther (Seoul) 2019;27:185–92. [PMC free article] [PubMed] [Google Scholar]
122. Bellei B, Papaccio F, Filoni A, Caputo S, Lopez G, Migliano E. et al. Extracellular fraction of adipose tissue as an innovative regenerative approach for vitiligo treatment. Exp Dermatol. 2019;28:695–703. [PubMed] [Google Scholar]
123. Bian Y, Yu H, Jin M, Gao X. Repigmentation by combined narrow-band ultraviolet B/adipose-derived stem cell transplantation in the mouse model: Role of Nrf2/HO-1-mediated Ca(2+) homeostasis. Mol Med Rep. 2022. 25. [PMC free article] [PubMed]
124. Castelli MS, McGonigle P, Hornby PJ. The pharmacology and therapeutic applications of monoclonal antibodies. Pharmacol Res Perspect. 2019;7:e00535. [PMC free article] [PubMed] [Google Scholar]
125. Jiang Y, Chen M, Nie H, Yuan Y. PD-1 and PD-L1 in cancer immunotherapy: clinical implications and future considerations. Hum Vaccin Immunother. 2019;15:1111–22. [PMC free article] [PubMed] [Google Scholar]
126. Yi M, Zheng X, Niu M, Zhu S, Ge H, Wu K. Combination strategies with PD-1/PD-L1 blockade: current advances and future directions. Mol Cancer. 2022;21:28. [PMC free article] [PubMed] [Google Scholar]
127. Rivera N, Boada A, Bielsa MI, Fernandez-Figueras MT, Carcereny E, Moran MT. et al. Hair Repigmentation During Immunotherapy Treatment With an Anti-Programmed Cell Death 1 and Anti-Programmed Cell Death Ligand 1 Agent for Lung Cancer. JAMA Dermatol. 2017;153:1162–5. [PMC free article] [PubMed] [Google Scholar]
128. Manson G, Marabelle A, Houot R. Hair Repigmentation With Anti-PD-1 and Anti-PD-L1 Immunotherapy: A Novel Hypothesis. JAMA Dermatol. 2018;154:113. [PubMed] [Google Scholar]
129. Sebaratnam DF, Rodriguez Bandera AI, Lowe PM. Hair Repigmentation With Anti-PD-1 and Anti-PD-L1 Immunotherapy: A Novel Hypothesis. JAMA Dermatol. 2018;154:112–3. [PubMed] [Google Scholar]
130. Park M, Woo SY, Cho KA, Cho MS, Lee KH. PD-L1 produced by HaCaT cells under polyinosinic-polycytidylic acid stimulation inhibits melanin production by B16F10 cells. PLoS One. 2020;15:e0233448. [PMC free article] [PubMed] [Google Scholar]
131. Quach HT, Johnson DB, LeBoeuf NR, Zwerner JP, Dewan AK. Cutaneous adverse events caused by immune checkpoint inhibitors. J Am Acad Dermatol. 2021;85:956–66. [PubMed] [Google Scholar]
132. Correa-Selm LM, Grichnik JM. PD1 inhibitors and hair repigmentation: A desirable new side effect. Dermatol Ther. 2018. 31. [PubMed]
133. Navarro-Trivino FJ, Ruiz-Villaverde R, Manuel Ramos-Pleguezuelos F, Vano-Galvan S. Canities Subita after Extreme Trauma Showing Positive Staining for Anti-PD-L1 Antibodies: A New Clue into Etiopathogenesis? Skin Appendage Disord. 2022;8:65–9. [PMC free article] [PubMed] [Google Scholar]
134. Harb H, Chatila TA. Mechanisms of Dupilumab. Clin Exp Allergy. 2020;50:5–14. [PMC free article] [PubMed] [Google Scholar]
135. Sumitomo C, Akita H, Sugiura K. Unexpected side-effect of dupilumab: Reversal of hair graying. J Dermatol. 2020;47:e316–e7. [PubMed] [Google Scholar]
136. Choi H, Choi H, Han J, Jin SH, Park JY, Shin DW. et al. IL-4 Inhibits the Melanogenesis of Normal Human Melanocytes through the JAK2-STAT6 Signaling Pathway. J Invest Dermatol. 2013;133:528–36. [PubMed] [Google Scholar]
137. Tintle S, Dabade T, Kalish R, Rosmarin D. Repigmentation of hair following adalimumab therapy. Dermatology online journal. 2015. 21. [PubMed]
138. Singh M, Mansuri MS, Kadam A, Palit SP, Dwivedi M, Laddha NC. et al. Tumor Necrosis Factor-alpha affects melanocyte survival and melanin synthesis via multiple pathways in vitiligo. Cytokine. 2021;140:155432. [PubMed] [Google Scholar]
139. Wang CQF, Akalu YT, Suarez-Farinas M, Gonzalez J, Mitsui H, Lowes MA. et al. IL-17 and TNF synergistically modulate cytokine expression while suppressing melanogenesis: potential relevance to psoriasis. J Invest Dermatol. 2013;133:2741–52. [PMC free article] [PubMed] [Google Scholar]
140. Grine L, Dejager L, Libert C, Vandenbroucke RE. An inflammatory triangle in psoriasis: TNF, type I IFNs and IL-17. Cytokine Growth Factor Rev. 2015;26:25–33. [PubMed] [Google Scholar]
141. Martínez-Esparza M, Jiménez-Cervantes C, Solano F, Lozano J, García-Borrón J. Regulation of the murine silver locus product (gp87) by the hypopigmenting cytokines TGF-beta1 and TNF-alpha. Pigment cell research. 2000;13:120–6. [PubMed] [Google Scholar]
142. Funasaka Y, Chakraborty A, Hayashi Y, Komoto M, Ohashi A, Nagahama M. et al. Modulation of melanocyte-stimulating hormone receptor expression on normal human melanocytes: evidence for a regulatory role of ultraviolet B, interleukin-1alpha, interleukin-1beta, endothelin-1 and tumour necrosis factor-alpha. The British journal of dermatology. 1998;139:216–24. [PubMed] [Google Scholar]
143. Choi H, Ahn S, Lee BG, Chang I, Hwang JS. Inhibition of skin pigmentation by an extract of Lepidium apetalum and its possible implication in IL-6 mediated signaling. Pigment Cell Res. 2005;18:439–46. [PubMed] [Google Scholar]
144. Choi H, Kim K, Han J, Choi H, Jin SH, Lee EK. et al. Kojic acid-induced IL-6 production in human keratinocytes plays a role in its anti-melanogenic activity in skin. J Dermatol Sci. 2012;66:207–15. [PubMed] [Google Scholar]
145. Jiang L, Huang J, Lu J, Hu S, Pei S, Ouyang Y. et al. Ganoderma lucidum polysaccharide reduces melanogenesis by inhibiting the paracrine effects of keratinocytes and fibroblasts via IL-6/STAT3/FGF2 pathway. J Cell Physiol. 2019;234:22799–808. [PubMed] [Google Scholar]
146. Camara-Lemarroy CR, Salas-Alanis JC. The role of tumor necrosis factor-alpha in the pathogenesis of vitiligo. Am J Clin Dermatol. 2013;14:343–50. [PubMed] [Google Scholar]
147. Manaka L, Kadono S, Kawashima M, Kobayashi T, Imokawa G. The mechanism of hyperpigmentation in seborrhoeic keratosis involves the high expression of endothelin-converting enzyme-1alpha and TNF-alpha, which stimulate secretion of endothelin 1. The British journal of dermatology. 2001;145:895–903. [PubMed] [Google Scholar]
148. Imokawa G. Melanocyte Activation Mechanisms and Rational Therapeutic Treatments of Solar Lentigos. Int J Mol Sci. 2019. 20. [PMC free article] [PubMed]
149. Takenaka Y, Hoshino Y, Nakajima H, Hayashi N, Kawashima M, Imokawa G. Paracrine cytokine mechanisms underlying the hyperpigmentation of seborrheic keratosis in covered skin areas. J Dermatol. 2013;40:533–42. [PubMed] [Google Scholar]
150. Lu Y, Tonissen KF, Di Trapani G. Modulating skin colour: role of the thioredoxin and glutathione systems in regulating melanogenesis. Biosci Rep. 2021. 41. [PMC free article] [PubMed]
151. Rongioletti F, Mugheddu C, Murgia S. Repigmentation and new growth of hairs after anti-interleukin-17 therapy with secukinumab for psoriasis. JAAD Case Rep. 2018;4:486–8. [PMC free article] [PubMed] [Google Scholar]
152. Zhou J, An X, Dong J, Wang Y, Zhong H, Duan L. et al. IL-17 induces cellular stress microenvironment of melanocytes to promote autophagic cell apoptosis in vitiligo. FASEB J. 2018;32:4899–916. [PubMed] [Google Scholar]
153. Kotobuki Y, Tanemura A, Yang L, Itoi S, Wataya-Kaneda M, Murota H. et al. Dysregulation of melanocyte function by Th17-related cytokines: significance of Th17 cell infiltration in autoimmune vitiligo vulgaris. Pigment Cell Melanoma Res. 2012;25:219–30. [PubMed] [Google Scholar]
154. Kholmanskikh O, van Baren N, Brasseur F, Ottaviani S, Vanacker J, Arts N. et al. Interleukins 1alpha and 1beta secreted by some melanoma cell lines strongly reduce expression of MITF-M and melanocyte differentiation antigens. Int J Cancer. 2010;127:1625–36. [PubMed] [Google Scholar]
155. Arts N, Cane S, Hennequart M, Lamy J, Bommer G, Van den Eynde B. et al. microRNA-155, induced by interleukin-1ss, represses the expression of microphthalmia-associated transcription factor (MITF-M) in melanoma cells. PLoS One. 2015;10:e0122517. [PMC free article] [PubMed] [Google Scholar]
156. Zhuang T, Li S, Yi X, Guo S, Wang Y, Chen J. et al. Tranilast Directly Targets NLRP3 to Protect Melanocytes From Keratinocyte-Derived IL-1beta Under Oxidative Stress. Front Cell Dev Biol. 2020;8:588. [PMC free article] [PubMed] [Google Scholar]
157. Yang CY, Guo Y, Wu WJ, Man MQ, Tu Y, He L. UVB-Induced Secretion of IL-1beta Promotes Melanogenesis by Upregulating TYR/TRP-1 Expression In vitro. Biomed Res Int. 2022;2022:8230646. [PMC free article] [PubMed] [Google Scholar]
158. Singh RK, Lee KM, Vujkovic-Cvijin I, Ucmak D, Farahnik B, Abrouk M. et al. The role of IL-17 in vitiligo: A review. Autoimmun Rev. 2016;15:397–404. [PMC free article] [PubMed] [Google Scholar]
159. Bernardini N, Skroza N, Tolino E, Mambrin A, Anzalone A, Balduzzi V. et al. IL-17 and its role in inflammatory, autoimmune, and oncological skin diseases: state of art. Int J Dermatol. 2020;59:406–11. [PMC free article] [PubMed] [Google Scholar]
160. Bhardwaj S, Rani S, Srivastava N, Kumar R, Parsad D. Increased systemic and epidermal levels of IL-17A and IL-1beta promotes progression of non-segmental vitiligo. Cytokine. 2017;91:153–61. [PubMed] [Google Scholar]
161. Tomaszewska K, Kozlowska M, Kaszuba A, Lesiak A, Narbutt J, Zalewska-Janowska A. Increased Serum Levels of IFN-gamma, IL-1beta, and IL-6 in Patients with Alopecia Areata and Nonsegmental Vitiligo. Oxid Med Cell Longev. 2020;2020:5693572. [PMC free article] [PubMed] [Google Scholar]
162. Di Cesare A, Fargnoli MC, Marinucci A, Peris K. Rationale for the development of speckled hyperpigmentation in the areas of psoriatic plaques after treatment with biologic agents. J Invest Dermatol. 2015;135:318–20. [PubMed] [Google Scholar]
163. Zhang S, Liang J, Tian X, Zhou X, Liu W, Chen X. et al. Secukinumab-induced multiple lentigines in areas of resolved psoriatic plaques: A case report and literature review. Dermatol Ther. 2021;34:e15048. [PubMed] [Google Scholar]
164. Park S, Ahn G, Park J, Seo S. The First Case of Ustekinumab-Associated Hair Repigmentation and a Proposed Mechanism of Action. Annals of dermatology. 2021;33:300–1. [PMC free article] [PubMed] [Google Scholar]
165. Armstrong AW, Read C. Pathophysiology, Clinical Presentation, and Treatment of Psoriasis: A Review. JAMA. 2020;323:1945–60. [PubMed] [Google Scholar]
166. Penzi LR, Manatis-Lornell A, Saavedra A, Fisher D, Senna MM. Hair repigmentation associated with the use of brentuximab. JAAD Case Rep. 2017;3:563–5. [PMC free article] [PubMed] [Google Scholar]
167. Deutsch YE, Tadmor T, Podack ER, Rosenblatt JD. CD30: an important new target in hematologic malignancies. Leuk Lymphoma. 2011;52:1641–54. [PubMed] [Google Scholar]
168. So T, Ishii N. The TNF-TNFR Family of Co-signal Molecules. Advances in experimental medicine and biology. 2019;1189:53–84. [PubMed] [Google Scholar]
169. Robert C, Spatz A, Faivre S, Armand JP, Raymond E. Tyrosine kinase inhibition and grey hair. Lancet. 2003;361:1056. [PubMed] [Google Scholar]
170. Kockerols C, Westerweel P. Hair Repigmentation Induced by Nilotinib. The New England journal of medicine. 2022;387:e12. [PubMed] [Google Scholar]
171. Cheng Y, Chen H, Chiu H. Erlotinib-induced hair repigmentation. International journal of dermatology. 2014;53:e55–7. [PubMed] [Google Scholar]
172. Robert C, Mateus C, Spatz A, Wechsler J, Escudier B. Dermatologic symptoms associated with the multikinase inhibitor sorafenib. J Am Acad Dermatol. 2009;60:299–305. [PubMed] [Google Scholar]
173. Cohen P, Cross D, Janne PA. Kinase drug discovery 20 years after imatinib: progress and future directions. Nat Rev Drug Discov. 2021;20:551–69. [PMC free article] [PubMed] [Google Scholar]
174. Quintás-Cardama A, Cortes J. Nilotinib: a phenylamino-pyrimidine derivative with activity against BCR-ABL, KIT and PDGFR kinases. Future oncology (London, England) 2008;4:611–21. [PubMed] [Google Scholar]
175. Contreras O, Villarreal M, Brandan E. Nilotinib impairs skeletal myogenesis by increasing myoblast proliferation. Skelet Muscle. 2018;8:5. [PMC free article] [PubMed] [Google Scholar]
176. Kim J, Lee HJ, Park JH, Cha BY, Hoe HS. Nilotinib modulates LPS-induced cognitive impairment and neuroinflammatory responses by regulating P38/STAT3 signaling. J Neuroinflammation. 2022;19:187. [PMC free article] [PubMed] [Google Scholar]
177. Jeitany M, Leroy C, Tosti P, Lafitte M, Le Guet J, Simon V, Inhibition of DDR1-BCR signalling by nilotinib as a new therapeutic strategy for metastatic colorectal cancer. EMBO Mol Med. 2018. 10. [PMC free article] [PubMed]
178. Wu J, Xu X, Zheng L, Mo J, Jin X, Bao Y. Nilotinib inhibits microglia-mediated neuroinflammation to protect against dopaminergic neuronal death in Parkinson's disease models. Int Immunopharmacol. 2021;99:108025. [PubMed] [Google Scholar]
179. Kim KI, Jo JW, Lee JH, Kim CD, Yoon TJ. Induction of pigmentation by a small molecule tyrosine kinase inhibitor nilotinib. Biochem Biophys Res Commun. 2018;503:2271–6. [PubMed] [Google Scholar]
180. Chang SP, Huang HM, Shen SC, Lee WR, Chen YC. Nilotinib induction of melanogenesis via reactive oxygen species-dependent JNK activation in B16F0 mouse melanoma cells. Exp Dermatol. 2018;27:1388–94. [PubMed] [Google Scholar]
181. Kang B, Kim Y, Park TJ, Kang HY. Dasatinib, a second-generation tyrosine kinase inhibitor, induces melanogenesis via ERK-CREB-MITF-tyrosinase signaling in normal human melanocytes. Biochem Biophys Res Commun. 2020;523:1034–9. [PubMed] [Google Scholar]
182. Jeong SM, Yoon TJ. Development of Pigmentation-Regulating Agents by Drug Repositioning. Int J Mol Sci. 2021. 22. [PMC free article] [PubMed]
183. Kim KI, Jung KE, Shin YB, Kim CD, Yoon TJ. Sorafenib induces pigmentation via the regulation of beta-catenin signalling pathway in melanoma cells. Exp Dermatol. 2022;31:57–63. [PubMed] [Google Scholar]
184. Steins M, Thomas M, Geissler M. Erlotinib. Recent Results Cancer Res. 2018;211:1–17. [PubMed] [Google Scholar]
185. Lin KY, Chen CM, Lu CY, Cheng CY, Wu YH. Regulation of miR-21 expression in human melanoma via UV-ray-induced melanin pigmentation. Environ Toxicol. 2017;32:2064–9. [PubMed] [Google Scholar]
186. Yun WJ, Bang SH, Min KH, Kim SW, Lee MW, Chang SE. Epidermal growth factor and epidermal growth factor signaling attenuate laser-induced melanogenesis. Dermatol Surg. 2013;39:1903–11. [PubMed] [Google Scholar]
187. AlGhamdi KM, Kumar A. Depigmentation therapies for normal skin in vitiligo universalis. J Eur Acad Dermatol Venereol. 2011;25:749–57. [PubMed] [Google Scholar]
188. Macdonald JB, Macdonald B, Golitz LE, LoRusso P, Sekulic A. Cutaneous adverse effects of targeted therapies: Part I: Inhibitors of the cellular membrane. J Am Acad Dermatol. 2015;72:203–18. quiz 19-20. [PubMed] [Google Scholar]
189. Zuo RC, Apolo AB, DiGiovanna JJ, Parnes HL, Keen CM, Nanda S. et al. Cutaneous adverse effects associated with the tyrosine-kinase inhibitor cabozantinib. JAMA Dermatol. 2015;151:170–7. [PMC free article] [PubMed] [Google Scholar]
190. Lovering S, Miao W, Bailie T, Amato D. Hair repigmentation associated with thalidomide use for the treatment of multiple myeloma. BMJ Case Rep. 2016. 2016. [PMC free article] [PubMed]
191. Dasanu CA, Mitsis D, Alexandrescu DT. Hair repigmentation associated with the use of lenalidomide: graying may not be an irreversible process! J Oncol Pharm Pract. 2013;19:165–9. [PubMed] [Google Scholar]
192. Zhu YX, Kortuem KM, Stewart AK. Molecular mechanism of action of immune-modulatory drugs thalidomide, lenalidomide and pomalidomide in multiple myeloma. Leuk Lymphoma. 2013;54:683–7. [PMC free article] [PubMed] [Google Scholar]
193. Chang X, Zhu Y, Shi C, Stewart AK. Mechanism of immunomodulatory drugs' action in the treatment of multiple myeloma. Acta Biochim Biophys Sin (Shanghai) 2014;46:240–53. [PMC free article] [PubMed] [Google Scholar]
194. Xu Y, Sun J, Sheard MA, Tran HC, Wan Z, Liu WY. et al. Lenalidomide overcomes suppression of human natural killer cell anti-tumor functions by neuroblastoma microenvironment-associated IL-6 and TGFbeta1. Cancer Immunol Immunother. 2013;62:1637–48. [PMC free article] [PubMed] [Google Scholar]
195. Liang CJ, Yen YH, Hung LY, Wang SH, Pu CM, Chien HF. et al. Thalidomide inhibits fibronectin production in TGF-beta1-treated normal and keloid fibroblasts via inhibition of the p38/Smad3 pathway. Biochem Pharmacol. 2013;85:1594–602. [PubMed] [Google Scholar]
196. Bian C, Qin WJ, Zhang CY, Zou GL, Zhu YZ, Chen J. et al. Thalidomide (THD) alleviates radiation induced lung fibrosis (RILF) via down-regulation of TGF-beta/Smad3 signaling pathway in an Nrf2-dependent manner. Free Radic Biol Med. 2018;129:446–53. [PubMed] [Google Scholar]
197. Lu Y, Zhao C, Lei L, Tao Z, Zheng L, Wen J. et al. Effects of thalidomide on Th17, Treg cells and TGF-beta1/Smad3 pathway in a mouse model of systemic sclerosis. Int J Rheum Dis. 2020;23:406–19. [PubMed] [Google Scholar]
198. Amirshahrokhi K, Khalili AR. Thalidomide ameliorates cisplatin-induced nephrotoxicity by inhibiting renal inflammation in an experimental model. Inflammation. 2015;38:476–84. [PubMed] [Google Scholar]
199. Paravar T, Lee DJ. Thalidomide: mechanisms of action. Int Rev Immunol. 2008;27:111–35. [PubMed] [Google Scholar]
200. Keifer JA, Guttridge DC, Ashburner BP, Baldwin AS Jr. Inhibition of NF-kappa B activity by thalidomide through suppression of IkappaB kinase activity. J Biol Chem. 2001;276:22382–7. [PubMed] [Google Scholar]
201. Fu C, Chen J, Lu J, Yi L, Tong X, Kang L. et al. Roles of inflammation factors in melanogenesis (Review) Mol Med Rep. 2020;21:1421–30. [PMC free article] [PubMed] [Google Scholar]
202. Zhou J, Ling J, Song J, Wang Y, Feng B, Ping F. Interleukin 10 protects primary melanocyte by activation of Stat-3 and PI3K/Akt/NF-kappaB signaling pathways. Cytokine. 2016;83:275–81. [PubMed] [Google Scholar]
203. Semeraro M, Vacchelli E, Eggermont A, Galon J, Zitvogel L, Kroemer G. et al. Trial Watch: Lenalidomide-based immunochemotherapy. Oncoimmunology. 2013;2:e26494. [PMC free article] [PubMed] [Google Scholar]
204. Englaro W, Bahadoran P, Bertolotto C, Buscà R, Dérijard B, Livolsi A. et al. Tumor necrosis factor alpha-mediated inhibition of melanogenesis is dependent on nuclear factor kappa B activation. Oncogene. 1999;18:1553–9. [PubMed] [Google Scholar]
205. Kim K, Choi H, Kim H, Lee T. TNFSF14 inhibits melanogenesis via NF-kB signaling in melanocytes. Cytokine. 2018;110:126–30. [PubMed] [Google Scholar]
206. Zhou J, Shang J, Song J, Ping F. Interleukin-18 augments growth ability of primary human melanocytes by PTEN inactivation through the AKT/NF-kappaB pathway. Int J Biochem Cell Biol. 2013;45:308–16. [PubMed] [Google Scholar]
207. Sun L, Pan S, Yang Y, Sun J, Liang D, Wang X. et al. Toll-like receptor 9 regulates melanogenesis through NF-kappaB activation. Exp Biol Med (Maywood) 2016;241:1497–504. [PMC free article] [PubMed] [Google Scholar]
208. Chaiprasongsuk A, Panich U. Role of Phytochemicals in Skin Photoprotection via Regulation of Nrf2. Front Pharmacol. 2022;13:823881. [PMC free article] [PubMed] [Google Scholar]
209. Bodera P, Stankiewicz W. Immunomodulatory properties of thalidomide analogs: pomalidomide and lenalidomide, experimental and therapeutic applications. Recent patents on endocrine, metabolic & immune drug discovery. 2011;5:192–6. [PubMed] [Google Scholar]
210. Wang Y, Viennet C, Robin S, Berthon JY, He L, Humbert P. Precise role of dermal fibroblasts on melanocyte pigmentation. J Dermatol Sci. 2017;88:159–66. [PubMed] [Google Scholar]
211. Kim NH, Lee AY. Growth Factors Upregulated by Uric Acid Affect Guanine Deaminase-Induced Melanogenesis. Biomol Ther (Seoul) 2023;31:89–96. [PMC free article] [PubMed] [Google Scholar]
212. Zhu JW, Ni YJ, Tong XY, Guo X, Wu XP. Activation of VEGF receptors in response to UVB promotes cell proliferation and melanogenesis of normal human melanocytes. Exp Cell Res. 2020;387:111798. [PubMed] [Google Scholar]
213. Zhu JW, Ni YJ, Tong XY, Guo X, Wu XP, Lu ZF. Tranexamic Acid Inhibits Angiogenesis and Melanogenesis in vitro by Targeting VEGF Receptors. Int J Med Sci. 2020;17:903–11. [PMC free article] [PubMed] [Google Scholar]
214. Amor KT, Ryan C, Menter A. The use of cyclosporine in dermatology: part I. J Am Acad Dermatol. 2010;63:925–46. quiz 47-8. [PubMed] [Google Scholar]
215. Rebora A, Delmonte S, Parodi A. Cyclosporin A-induced hair darkening. International journal of dermatology. 1999;38:229–30. [PubMed] [Google Scholar]
216. Sadighha A, Zahed GM. Hair darkening after treatment with cyclosporin in a patient with psoriasis. J Eur Acad Dermatol Venereol. 2008;22:1239–41. [PubMed] [Google Scholar]
217. Gohar A. Comment on the letter by Sadighha and Zahed on Hair darkening after treatment with cyclosporin in a patient with psoriasis. Journal of the European Academy of Dermatology and Venereology: JEADV. 2009;23:862. [PubMed] [Google Scholar]
218. Hawkshaw NJ, Paus R. Beyond the NFAT Horizon: From Cyclosporine A-Induced Adverse Skin Effects to Novel Therapeutics. Trends Pharmacol Sci. 2021;42:316–28. [PubMed] [Google Scholar]
219. Hawkshaw NJ, Hardman JA, Haslam IS, Shahmalak A, Gilhar A, Lim X. et al. Identifying novel strategies for treating human hair loss disorders: Cyclosporine A suppresses the Wnt inhibitor, SFRP1, in the dermal papilla of human scalp hair follicles. PLoS Biol. 2018;16:e2003705. [PMC free article] [PubMed] [Google Scholar]
220. Redondo P, Guzmán M, Marquina M, Pretel M, Aguado L, Lloret P. et al. [Repigmentation of gray hair after thyroid hormone treatment] Actas dermo-sifiliograficas. 2007;98:603–10. [PubMed] [Google Scholar]
221. van Beek N, Bodo E, Kromminga A, Gaspar E, Meyer K, Zmijewski MA. et al. Thyroid hormones directly alter human hair follicle functions: anagen prolongation and stimulation of both hair matrix keratinocyte proliferation and hair pigmentation. J Clin Endocrinol Metab. 2008;93:4381–8. [PubMed] [Google Scholar]
222. Hardman JA, Haslam IS, Farjo N, Farjo B, Paus R. Thyroxine differentially modulates the peripheral clock: lessons from the human hair follicle. PLoS One. 2015;10:e0121878. [PMC free article] [PubMed] [Google Scholar]
223. Mancino G, Miro C, Di Cicco E, Dentice M. Thyroid hormone action in epidermal development and homeostasis and its implications in the pathophysiology of the skin. J Endocrinol Invest. 2021;44:1571–9. [PMC free article] [PubMed] [Google Scholar]
224. Di Cicco E, Moran C, Visser WE, Nappi A, Schoenmakers E, Todd P. et al. Germ Line Mutations in the Thyroid Hormone Receptor Alpha Gene Predispose to Cutaneous Tags and Melanocytic Nevi. Thyroid. 2021;31:1114–26. [PMC free article] [PubMed] [Google Scholar]
225. Bellandi S, Amato L, Cipollini E, Antiga E, Brandini L, Fabbri P. Repigmentation of hair after latanoprost therapy. Journal of the European Academy of Dermatology and Venereology: JEADV. 2011;25:1485–7. [PubMed] [Google Scholar]
226. Digiuni M, Fogagnolo P, Rossetti L. A review of the use of latanoprost for glaucoma since its launch. Expert opinion on pharmacotherapy. 2012;13:723–45. [PubMed] [Google Scholar]
227. Scott G, Leopardi S, Printup S, Malhi N, Seiberg M, Lapoint R. Proteinase-activated receptor-2 stimulates prostaglandin production in keratinocytes: analysis of prostaglandin receptors on human melanocytes and effects of PGE2 and PGF2alpha on melanocyte dendricity. The Journal of investigative dermatology. 2004;122:1214–24. [PubMed] [Google Scholar]
228. Scott G, Jacobs S, Leopardi S, Anthony FA, Learn D, Malaviya R. et al. Effects of PGF2alpha on human melanocytes and regulation of the FP receptor by ultraviolet radiation. Exp Cell Res. 2005;304:407–16. [PubMed] [Google Scholar]
229. Gledhill K, Rhodes LE, Brownrigg M, Haylett AK, Masoodi M, Thody AJ. et al. Prostaglandin-E2 is produced by adult human epidermal melanocytes in response to UVB in a melanogenesis-independent manner. Pigment Cell Melanoma Res. 2010;23:394–403. [PMC free article] [PubMed] [Google Scholar]
230. Starner RJ, McClelland L, Abdel-Malek Z, Fricke A, Scott G. PGE(2) is a UVR-inducible autocrine factor for human melanocytes that stimulates tyrosinase activation. Exp Dermatol. 2010;19:682–4. [PMC free article] [PubMed] [Google Scholar]
231. Ma HJ, Ma HY, Yang Y, Li PC, Zi SX, Jia CY. et al. alpha-Melanocyte stimulating hormone (MSH) and prostaglandin E2 (PGE2) drive melanosome transfer by promoting filopodia delivery and shedding spheroid granules: Evidences from atomic force microscopy observation. J Dermatol Sci. 2014;76:222–30. [PubMed] [Google Scholar]
232. Shin DW. The physiological and pharmacological roles of prostaglandins in hair growth. Korean J Physiol Pharmacol. 2022;26:405–13. [PMC free article] [PubMed] [Google Scholar]
233. Yazdanian N, Mozafarpoor S, Goodarzi A. Phosphodiesterase inhibitors and prostaglandin analogues in dermatology: A comprehensive review. Dermatol Ther. 2021;34:e14669. [PubMed] [Google Scholar]
234. Sasaki S, Hozumi Y, Kondo S. Influence of prostaglandin F2alpha and its analogues on hair regrowth and follicular melanogenesis in a murine model. Experimental dermatology. 2005;14:323–8. [PubMed] [Google Scholar]
235. Chan LKM, Braidy N, Ng W, Xu YH, Chen J, McDonald R. et al. Re-pigmentation of hair after prolonged cholinesterase inhibitor therapy in a Chinese population. Australas J Dermatol. 2020;61:e417–e20. [PubMed] [Google Scholar]
236. Wu Q, Xia Y, Dai K, Bai P, Kwan KKL, Guo MSS. et al. Solar light induces the release of acetylcholine from skin keratinocytes affecting melanogenesis. FASEB J. 2020;34:8941–58. [PubMed] [Google Scholar]
237. Wu Q, Fung AHY, Xu ML, Poon K, Liu EYL, Kong XP. et al. Microphthalmia-associated transcription factor up-regulates acetylcholinesterase expression during melanogenesis of murine melanoma cells. J Biol Chem. 2018;293:14417–28. [PMC free article] [PubMed] [Google Scholar]
238. Wu Q, Bai P, Xia Y, Lai QWS, Guo MSS, Dai K. et al. Solar light induces expression of acetylcholinesterase in skin keratinocytes: Signalling mediated by activator protein 1 transcription factor. Neurochem Int. 2020;141:104861. [PubMed] [Google Scholar]
239. Guo M, Wu Q, Dong T, Tsim K. The UV-induced uptake of melanosome by skin keratinocyte is triggered by α7 nicotinic acetylcholine receptor-mediated phagocytosis. The FEBS journal. 2022. [PubMed]
240. Hasse S, Chernyavsky AI, Grando SA, Paus R. The M4 muscarinic acetylcholine receptor plays a key role in the control of murine hair follicle cycling and pigmentation. Life Sci. 2007;80:2248–52. [PMC free article] [PubMed] [Google Scholar]
241. Enkhtaivan E, Lee CH. Role of Amine Neurotransmitters and Their Receptors in Skin Pigmentation: Therapeutic Implication. Int J Mol Sci. 2021. 22. [PMC free article] [PubMed]
242. Takahashi T. Multiple Roles for Cholinergic Signaling from the Perspective of Stem Cell Function. Int J Mol Sci. 2021. 22. [PMC free article] [PubMed]
243. Hampson J, Donnelly A, Lewis-Jones M, Pye J. Tamoxifen-induced hair colour change. The British journal of dermatology. 1995;132:483–4. [PubMed] [Google Scholar]
244. Cario M. How hormones may modulate human skin pigmentation in melasma: An in vitro perspective. Exp Dermatol. 2019;28:709–18. [PubMed] [Google Scholar]
245. Jian D, Jiang D, Su J, Chen W, Hu X, Kuang Y. et al. Diethylstilbestrol enhances melanogenesis via cAMP-PKA-mediating up-regulation of tyrosinase and MITF in mouse B16 melanoma cells. Steroids. 2011;76:1297–304. [PubMed] [Google Scholar]
246. Sun M, Xie HF, Tang Y, Lin SQ, Li JM, Sun SN. et al. G protein-coupled estrogen receptor enhances melanogenesis via cAMP-protein kinase (PKA) by upregulating microphthalmia-related transcription factor-tyrosinase in melanoma. J Steroid Biochem Mol Biol. 2017;165:236–46. [PubMed] [Google Scholar]
247. Filoni A, Mariano M, Cameli N. Melasma: How hormones can modulate skin pigmentation. J Cosmet Dermatol. 2019;18:458–63. [PubMed] [Google Scholar]
248. Matama T, Araujo R, Preto A, Cavaco-Paulo A, Gomes AC. In vitro induction of melanin synthesis and extrusion by tamoxifen. Int J Cosmet Sci. 2013;35:368–74. [PubMed] [Google Scholar]
249. Yang G, Nowsheen S, Aziz K, Georgakilas AG. Toxicity and adverse effects of Tamoxifen and other anti-estrogen drugs. Pharmacol Ther. 2013;139:392–404. [PubMed] [Google Scholar]
250. Komagamine T, Suzuki K, Hirata K. Darkening of white hair following levodopa therapy in a patient with Parkinson's disease. Mov Disord. 2013;28:1643. [PubMed] [Google Scholar]
251. Slominski A, Zmijewski MA, Pawelek J. L-tyrosine and L-dihydroxyphenylalanine as hormone-like regulators of melanocyte functions. Pigment Cell Melanoma Res. 2012;25:14–27. [PMC free article] [PubMed] [Google Scholar]
252. Langan EA, Lisztes E, Biro T, Funk W, Kloepper JE, Griffiths CE. et al. Dopamine is a novel, direct inducer of catagen in human scalp hair follicles in vitro. Br J Dermatol. 2013;168:520–5. [PubMed] [Google Scholar]
253. Villarreal-Reyna G, Garza-Morales R, Soto-Dominguez A, Montanez-Guerrero L, Saucedo-Cardenas O, Gomez-Flores M. et al. Cerebrolysin induces hair repigmentation associated to MART-1/Melan-A reactivation. Eur J Med Res. 2022;27:257. [PMC free article] [PubMed] [Google Scholar]
254. Botchkarev V, Botchkareva N, Albers K, Chen L, Welker P, Paus R. A role for p75 neurotrophin receptor in the control of apoptosis-driven hair follicle regression. FASEB journal: official publication of the Federation of American Societies for Experimental Biology. 2000;14:1931–42. [PubMed] [Google Scholar]
255. Nagase K, Inoue T, Narisawa Y. Manifest hair repigmentation associated with etretinate therapy. J Dermatol. 2017;44:e34–e5. [PubMed] [Google Scholar]
256. Seckin D, Yildiz A. Repigmentation and curling of hair after acitretin therapy. Australas J Dermatol. 2009;50:214–6. [PubMed] [Google Scholar]
257. Ward PD, Miller HL, Shipman AR. A case of repigmentation and curling of hair on acitretin therapy. Clin Exp Dermatol. 2014;39:91–2. [PubMed] [Google Scholar]
258. Vesper J, Fenske N. Hair darkening and new growth associated with etretinate therapy. Journal of the American Academy of Dermatology. 1996;34:860. [PubMed] [Google Scholar]
259. VanBuren CA, Everts HB. Vitamin A in Skin and Hair: An Update. Nutrients. 2022. 14. [PMC free article] [PubMed]
260. Wang Z, Coleman DJ, Bajaj G, Liang X, Ganguli-Indra G, Indra AK. RXRalpha ablation in epidermal keratinocytes enhances UVR-induced DNA damage, apoptosis, and proliferation of keratinocytes and melanocytes. J Invest Dermatol. 2011;131:177–87. [PMC free article] [PubMed] [Google Scholar]
261. Taguchi N, Hata T, Kamiya E, Homma T, Kobayashi A, Aoki H. et al. Eriodictyon angustifolium extract, but not Eriodictyon californicum extract, reduces human hair greying. Int J Cosmet Sci. 2020;42:336–45. [PubMed] [Google Scholar]
262. Taguchi N, Homma T, Aoki H, Kunisada T. Dietary Eriodictyon angustifolium Tea Supports Prevention of Hair Graying by Reducing DNA Damage in CD34+ Hair Follicular Keratinocyte Stem Cells. Biological & pharmaceutical bulletin. 2020;43:1451–4. [PubMed] [Google Scholar]
263. Taguchi N, Hata T, Kamiya E, Kobayashi A, Aoki H, Kunisada T. Reduction in human hair graying by sterubin, an active flavonoid of Eriodictyon angustifolium. J Dermatol Sci. 2018;92:286–9. [PubMed] [Google Scholar]
264. Taguchi N, Kitai R, Ando T, Nishimura T, Aoki H, Kunisada T. Protective Effect of Hydroxygenkwanin against Hair Graying Induced by X-Ray Irradiation and Repetitive Plucking. JID Innov. 2022;2:100121. [PMC free article] [PubMed] [Google Scholar]
265. Han MN, Lu JM, Zhang GY, Yu J, Zhao RH. Mechanistic Studies on the Use of Polygonum multiflorum for the Treatment of Hair Graying. Biomed Res Int. 2015;2015:651048. [PMC free article] [PubMed] [Google Scholar]
266. Sextius P, Betts R, Benkhalifa I, Commo S, Eilstein J, Massironi M. et al. Polygonum multiflorum Radix extract protects human foreskin melanocytes from oxidative stress in vitro and potentiates hair follicle pigmentation ex vivo. International journal of cosmetic science. 2017;39:419–25. [PubMed] [Google Scholar]
267. Thang ND, Diep PN, Lien PT, Lien LT. Polygonum multiflorum root extract as a potential candidate for treatment of early graying hair. J Adv Pharm Technol Res. 2017;8:8–13. [PMC free article] [PubMed] [Google Scholar]
268. Jo SJ, Shin H, Paik SH, Na SJ, Jin Y, Park WS. et al. Efficacy and Safety of Pueraria lobata Extract in Gray Hair Prevention: A Randomized, Double-Blind, Placebo-Controlled Study. Ann Dermatol. 2013;25:218–22. [PMC free article] [PubMed] [Google Scholar]
269. Park WS, Kwon O, Yoon TJ, Chung JH. Anti-graying effect of the extract of Pueraria thunbergiana via upregulation of cAMP/MITF-M signaling pathway. J Dermatol Sci. 2014;75:153–5. [PubMed] [Google Scholar]
270. Chavez A, Tiger J. Hair Repigmentation After Mohs Micrographic Surgery and Secondary Intention Wound Healing on the Scalp of an 84-Year-Old Woman. Dermatologic surgery: official publication for American Society for Dermatologic Surgery [et al] 2021;47:1281–3. [PubMed] [Google Scholar]
271. Kubelis-Lopez DE, Zapata-Salazar NA, Said-Fernandez SL, Sanchez-Dominguez CN, Salinas-Santander MA, Martinez-Rodriguez HG. et al. Updates and new medical treatments for vitiligo (Review) Exp Ther Med. 2021;22:797. [PMC free article] [PubMed] [Google Scholar]
272. Ziaeifar E, Ziaeifar F, Mozafarpoor S, Goodarzi A. Applications of microneedling for various dermatologic indications with a special focus on pigmentary disorders: A comprehensive review study. Dermatologic therapy. 2021;34:e15159. [PubMed] [Google Scholar]
273. York K, Meah N, Bhoyrul B, Sinclair R. A review of the treatment of male pattern hair loss. Expert Opin Pharmacother. 2020;21:603–12. [PubMed] [Google Scholar]
274. Yuriguchi M, Aoki H, Taguchi N, Kunisada T. Pigmentation of regenerated hairs after wounding. Journal of Dermatological Science. 2016;84:80–7. [PubMed] [Google Scholar]
275. Goldstein NB, Koster MI, Jones KL, Gao B, Hoaglin LG, Robinson SE. et al. Repigmentation of Human Vitiligo Skin by NBUVB Is Controlled by Transcription of GLI1 and Activation of the beta-Catenin Pathway in the Hair Follicle Bulge Stem Cells. J Invest Dermatol. 2018;138:657–68. [PMC free article] [PubMed] [Google Scholar]
276. Han X, Chang L, Qiu Z, Lin M, Wang Y, Liu D. et al. Micro-Injury Induces Hair Regeneration and Vitiligo Repigmentation Through Wnt/beta-Catenin Pathway. Stem Cells Dev. 2022;31:111–8. [PubMed] [Google Scholar]
277. Li H, Fan L, Zhu S, Shin MK, Lu F, Qu J. et al. Epilation induces hair and skin pigmentation through an EDN3/EDNRB-dependent regenerative response of melanocyte stem cells. Sci Rep. 2017;7:7272. [PMC free article] [PubMed] [Google Scholar]
278. Dummer R. Clinical picture: hair repigmentation in lentigo maligna. Lancet. 2001;357:598. [PubMed] [Google Scholar]
279. Rahim RR, Husain A, Tobin DJ, Lawrence CM. Desmoplastic melanoma presenting with localized hair repigmentation. Br J Dermatol. 2013;169:1371–3. [PubMed] [Google Scholar]
280. Inzinger M, Massone C, Arzberger E, Hofmann-Wellenhof R. Hair repigmentation in melanoma. Lancet. 2013;382:1224. [PubMed] [Google Scholar]
281. Tiger JB, Habeshian KA, Barton DT, Brennick JB. Repigmentation of hair associated with melanoma in situ of scalp. J Am Acad Dermatol. 2014;71:e144–5. [PubMed] [Google Scholar]
282. Amann VC, Dummer R. Localized Hair Repigmentation in a 91-Year-Old Woman. JAMA Dermatol. 2016;152:81–2. [PubMed] [Google Scholar]
283. Chan C, Magro C, Pham A, LeBlanc R, Yan S, Barton D. et al. Spontaneous Hair Repigmentation in an 80-Year-Old Man: A Case of Melanoma-Associated Hair Repigmentation and Review of the Literature. The American Journal of dermatopathology. 2019;41:671–4. [PubMed] [Google Scholar]
284. Lackey AE, Glassman G, Grichnik J, McDonald J, Correa-Selm L. Repigmentation of gray hairs with lentigo maligna and response to topical imiquimod. JAAD Case Rep. 2019;5:1015–7. [PMC free article] [PubMed] [Google Scholar]
285. Lopez-Sanchez C, Collgros H. Hair repigmentation as a clue for scalp melanoma. Australas J Dermatol. 2020;61:179–80. [PubMed] [Google Scholar]
286. Chew T, Pannell M, Jeeves A. Focal hair re-pigmentation associated with melanoma of the scalp. ANZ J Surg. 2020;90:1175–6. [PubMed] [Google Scholar]
287. Hasegawa T, Iino S, Kitakaze K, Kato T, Kabata D, Oyama N. et al. Repigmentation of aging gray hair associated with unrecognized development and progression of amelanotic melanoma of the scalp: A physiological alert underlying hair rejuvenation. J Dermatol. 2021;48:e281–e3. [PubMed] [Google Scholar]
288. Paus R. A neuroendocrinological perspective on human hair follicle pigmentation. Pigment Cell Melanoma Res. 2011;24:89–106. [PubMed] [Google Scholar]
